好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

April 5-9 | San Diego & Online

Join us for super science, powerful learning, and networking with neurology heroes from around the globe.

Explore Quick Links
Back to Program

Annual Meeting: Browse Plenary Sessions

The 2025 Annual Meeting plenary sessions feature leaders in the neurology field presenting the latest and greatest in breakthrough research, controversial issues, and more.

Controversies in Neurology Plenary Session

Join us on Saturday, April 5, from 9:15 a.m. to 11:15 a.m. PT, to hear experts dive into the most current and controversial issues in neurology, with experts engaging in a debate format where two speakers argue a side of a single topic, followed by a rebuttal.

  • Kathleen Poston, MD, FAAN, Stanford University Kathleen Poston, MD, FAAN, Stanford University

    Yes: Biomarker-based Diagnosis of Parkinson’s Disease: Are We Ready to Adopt a Biological Definition in Research?

  • headshot of Paolo Calabresi, MD, Policlinico Gemelli Paolo Calabresi, MD, Policlinico Gemelli

    No: Biomarker-based Diagnosis of Parkinson’s Disease: Are We Ready to Adopt a Biological Definition in Research?

  • Venkatasubramanian MD headshot Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS, Stanford University

    Yes: Blood Pressure Targets in ICH: Should We Go Low?

  • Kara R. Melmed, MD headshot Kara R. Melmed, MD, NYU Langone Health

    No: Blood Pressure Targets in ICH: Should We Go Low?

  • Andrew Charles, MD headshot Andrew Charles, MD, UCLA

    Yes: Should CGRP Antagonists Be First Line for Migraine Treatment?

  • Elizabeth Loder, MD, MPH headshot Elizabeth Loder, MD, MPH, Brigham and Women’s Hospital

    No: Should CGRP Antagonists Be First Line for Migraine Treatment?

View Session Details

Hot Topics in Neurology Plenary Session

Join us on Saturday, April 5, from 4:45 p.m. to 5:45 p.m. PT, to hear highlights of the latest, cutting-edge translational research on key clinical issues, presented by three outstanding speakers. They will summarize their recent research findings and discuss the clinical implications of the results.

  • headshot of Stephanie R. Miller, PhD, Gladstone Institutes Stephanie R. Miller, PhD, Gladstone Institutes

    AI and Biomarkers for Early Disease Prediction

  • Paul Edison headshot Paul Edison, MBBS, PhD, FRCPI, Imperial College London

    GLP1 Receptor Agonists: A Panacea or Too Good to Be True?

  • Leigh R. Hochberg, MD, PhD, FAAN headshot Leigh R. Hochberg, MD, PhD, FAAN, Massachusetts General Hospital

    Implantable Brain-Computer Interfaces for the Restoration of Communication and Mobility

View Session Details

Presidential Plenary Session

Join us on Sunday, April 6, from 9:15 a.m. to 12:00 p.m. PT, for this session featuring the AAN's premier lecture awards, where leading investigators will present the most significant and clinically relevant neurology research findings of 2025.

  • Carlayne Jackson Carlayne E. Jackson, MD, FAAN, University of Texas Health Science Center at San Antonio

    Presidential Lecture

  • Headshot of Roy H. Hamilton Roy H. Hamilton, MD, MS, FAAN, University of Pennsylvania Perelman School of Medicine

    H. Houston Merritt Lecture: Rewiring the Mind: Noninvasive Brain Stimulation Approaches to Translational Neurorehabilitation

  • Connolly, Anne headshot Anne M. Connolly, MD, FAAN, Nationwide Children’s Hospital

    Sidney Carter Award in Child Neurology: Corticosteroids: The First Neuromuscular Treatment Hammer I was Given

  • Cudkowicz, Merit headshot Merit E. Cudkowicz, MD, MSc, FAAN, Massachusetts General Hospital

    AAN Lifetime Achievement Award for Clinically-relevant Research: Fast-Tracking Discovery in ALS: Collaboration, Innovation, and Open Science

View Session Details

Contemporary Clinical Issues Plenary Session

Join us on Monday, April 7, from 9:15 a.m. to 11:00 a.m. PT, as we highlight the most critical issues for practicing neurologists, including abstracts related to therapeutic developments, clinical applications of basic and translational research, and innovative technical advancements already impacting the practice of neurology.

  • Mary C. Zuniga, MD headshot Mary C. Zuniga, MD, University of California, san francisco

    Presenter: Association Between Non-English Language Preference, Delirium Occurrence, and Inpatient Outcomes

  • headshot of Nicole Gonzales, MD, University of Colorado Nicole Gonzales, MD, University of Colorado

    Discussant: Association Between Non-English Language Preference, Delirium Occurrence, and Inpatient Outcomes

  • Robin van Steenhoven, MD headshot Robin van Steenhoven, MD, Erasmus University Medical Center

    Presenter: Autoimmune Encephalitis Is the Most Common Treatment-Responsive Cause of Rapidly Progressive Dementia: A Large Dutch Prospective Cohort Study

  • Stacey L. Clardy, MD, PhD headshot Stacey L. Clardy, MD, PhD, University of Utah

    Discussant: Autoimmune Encephalitis Is the Most Common Treatment-Responsive Cause of Rapidly Progressive Dementia: A Large Dutch Prospective Cohort Study

  • Riley Bove, MD, FAAN headshot Riley Bove, MD, FAAN, University of california, san francisco

    Presenter: Placental and Breastmilk Transfer of Ocrelizumab from Women with Multiple Sclerosis to Infants and the Potential Impact on B-Cell Levels: Primary Analysis of the Prospective, Multicenter, Open-label, Phase IV Studies MINORE and SOPRANINO

  • headshot of Sandra Vukusic, MD, Lyon University Hospital Sandra Vukusic, MD, Lyon University Hospital

    Discussant: Placental and Breastmilk Transfer of Ocrelizumab from Women with Multiple Sclerosis to Infants and the Potential Impact on B-Cell Levels: Primary Analysis of the Prospective, Multicenter, Open-label, Phase IV Studies MINORE and SOPRANINO

  • Thomas Khodadad headshot Thomas Khodadad, University of Vermont

    Presenter: Impact of Rurality on Treatment and Survival in Patients with Brain Metastases

  • Antonio M. P. Omuro, MD, FAAN headshot Antonio M. P. Omuro, MD, FAAN, Stanford University

    Discussant: Impact of Rurality on Treatment and Survival in Patients with Brain Metastases

  • Isabella Montano headshot Isabella Montano, Oregon Health and Science University

    Presenter: Obstructive Sleep Apnea is a Risk Factor for Parkinson’s Disease and CPAP Mitigates Risk of PD: An EHR-based Cohort Study in Military Veterans

  • Roneil Malkani, MD headshot Roneil Malkani, MD, Northwestern University

    Discussant: Obstructive Sleep Apnea is a Risk Factor for Parkinson’s Disease and CPAP Mitigates Risk of PD: An EHR-based Cohort Study in Military Veterans

View Session Details

Clinical Trials Plenary Session

Join us on Tuesday, April 8, from 9:15 a.m. to 11:30 a.m. PT, as we cover landmark clinical trials that affect patient care in every subspecialty of neurology with investigators presenting the latest clinical trials results that are impacting the landscape of neurological care.

  • Feigin headshot Andrew S. Feigin, MD, NYU Langone Health

    The Phase 3 PROOF-HD Trial Demonstrates Meaningful Benefits of Pridopidine on Function, Cognition, and Motor Signs in Huntington Disease (HD)

  • Christina Szperka, MD headshot Christina Szperka, MD, MSCE, Children’s Hospital of Philadelphia

    Efficacy and Safety of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

  • Robert J. Fox, MD, FAAN, Cleveland Clinic headshot Robert J. Fox, MD, FAAN, Cleveland Clinic

    Tolebrutinib Versus Placebo in Non-relapsing Secondary Progressive Multiple Sclerosis: Efficacy and Safety Results from the Phase 3 HERCULES Trial

  • Jiwon Oh, MD, FAAN headshot Jiwon Oh, MD, FAAN, University of Toronto

    Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Efficacy and Safety Results from the Phase 3 GEMINI 1 and 2 Trials

  • Richard Nowak, MD, MS headshot Richard Nowak, MD, MS, Yale School of Medicine

    Phase 3 Myasthenia Gravis Inebilizumab Trial (MINT): Efficacy and Safety Results in Patients with Generalized MG

  • headshot of Silhouette of a man Jeffrey A. Allen, MD, University of Minnesota Jeffrey A. Allen, MD, University of Minnesota

    Efficacy and Safety of Targeted Immunotherapy with ANX005 in Treating Guillain-Barré Syndrome: A Phase 3 Multicenter Study

  • Michael J. Thorpy, MD headshot Michael J. Thorpy, MD, Albert Einstein College of Medicine

    AXS-12 for the Treatment of Narcolepsy: Topline Results from the Phase 3 SYMPHONY Trial

View Session Details

Frontiers in Neuroscience Plenary Session

Join us on Wednesday, April 9, from 9:15 a.m. to 11:30 a.m. PT, for this session featuring basic and translational research related to clinical issues of importance with six outstanding speakers summarizing their recent research finding and diving into the clinical implications of the results.

  • Headshot of Ertekin Taner-Nifuler Nilufer Ertekin-Taner, MD, PhD, FAAN, Mayo Clinic

    A Roadmap to Precision Medicine in Neurodegenerative Diseases

  • Jerzy Szablowski, PhD headshot Jerzy Szablowski, PhD, Rice University

    Bioengineering Tools for Noninvasive Control and Monitoring of the Brain

  • Beth Malow headshot Beth A. Malow, MD, MS, FAAN, Vanderbilt University Medical Center

    Impact of Climate Change on Global Brain Health

  • Headshot of William Freeman William D. Freeman, MD, FAAN, Mayo Clinic

    Precision Medicine in Neurology: Cutting Edge and Emerging Pharmacogenomics for Personalized Neurological Care

  • Headshot of Michel Sadelain Michel Sadelain, MD, PhD, Columbia University

    CAR-T Therapy

View Session Details

Neurology Year in Review Plenary Session

Showcases six speakers focusing on the latest developments of interest to the clinician that have occurred in a specific subspecialty topic. Session details will be available shortly after the live meeting.

  • Jennifer A. Vermilion, MD headshot Jennifer A. Vermilion, MD, University of Rochester Medical Center

    Breakthrough Therapies for Pediatric Neurological Disorders

  • Sasha Alick-Lindstrom, MD, MD, MPH, FACNS, FAES, FAAN headshot Sasha Alick-Lindstrom, MD, MPH, FACNS, FAES, FAAN, UT Southwestern Medical Center

    Surgical Treatments for Epilepsy

  • headshot of Okeanis Vaou, MD, FAAN, UT Health San Antonio Okeanis Vaou, MD, FAAN, UT Health San Antonio

    Updates in the Management of Advanced Parkinson’s Disease

  • Karissa Gable, MD headshot Karissa Gable, MD, Duke University

    Updates in Myasthenia Gravis

  • headshot of Ronda Lun, MD, University of Calgary Ronda Lun, MD, University of Calgary

    Thrombectomy for Large Core Ischemic Strokes

  • headshot of John Winkelman, MD, PhD, Harvard Medical School John Winkelman, MD, PhD, Harvard Medical School

    New Perspectives on Restless Legs Syndrome Management